Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04614636
Title FT538 in Subjects With Advanced Hematologic Malignancies
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fate Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Colorado Blood Cancer Institute Denver Colorado 80218 United States Details
University of Minnesota Masonic Cancer Center Minneapolis Minnesota 55455 United States Details
Washington University Saint Louis Missouri 63110 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Sarah Cannon Research Institute at Tennessee Oncology Nashville Tennessee 37203 United States Details
St. David's South Austin Medical Center Austin Texas 78704 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Texas Transplant Institute San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field